These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
906 related articles for article (PubMed ID: 26590432)
21. RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites. Campo JJ; Aponte JJ; Skinner J; Nakajima R; Molina DM; Liang L; Sacarlal J; Alonso PL; Crompton PD; Felgner PL; Dobaño C Mol Cell Proteomics; 2015 Mar; 14(3):519-31. PubMed ID: 25547414 [TBL] [Abstract][Full Text] [Related]
22. The Delay in the Licensing of Protozoal Vaccines: A Comparative History. Palatnik-de-Sousa CB; Nico D Front Immunol; 2020; 11():204. PubMed ID: 32210953 [TBL] [Abstract][Full Text] [Related]
23. Malaria vaccines and human immune responses. Long CA; Zavala F Curr Opin Microbiol; 2016 Aug; 32():96-102. PubMed ID: 27262417 [TBL] [Abstract][Full Text] [Related]
24. [Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes]. Uyar Y; Akşit A; Karaca S; Ceylan ŞS; Yürük M Mikrobiyol Bul; 2017 Jan; 51(1):41-51. PubMed ID: 28283009 [TBL] [Abstract][Full Text] [Related]
25. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites. Atre T; Robinson TM; Savransky T; Dutta S; Epstein JE; Bergmann-Leitner ES Malar J; 2019 May; 18(1):186. PubMed ID: 31142328 [TBL] [Abstract][Full Text] [Related]
27. Development of malaria vaccines that block transmission of parasites by mosquito vectors. Hisaeda H; Yasutomo K J Med Invest; 2002 Aug; 49(3-4):118-23. PubMed ID: 12323000 [TBL] [Abstract][Full Text] [Related]
28. RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap. Kaslow DC; Biernaux S Vaccine; 2015 Dec; 33(52):7425-32. PubMed ID: 26431982 [TBL] [Abstract][Full Text] [Related]
29. Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses. White M; Amino R; Mueller I Trends Parasitol; 2017 Apr; 33(4):260-263. PubMed ID: 28077251 [TBL] [Abstract][Full Text] [Related]
30. Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria. Stanisic DI; Ho MF; Nevagi R; Cooper E; Walton M; Islam MT; Hussein WM; Skwarczynski M; Toth I; Good MF mBio; 2021 Oct; 12(5):e0265721. PubMed ID: 34663097 [TBL] [Abstract][Full Text] [Related]
31. Malaria vaccine: a bright prospect for elimination of malaria. Bairwa M; Rajput M; Khanna P; Rohilla R; Verma R; Chawla S Hum Vaccin Immunother; 2012 Jun; 8(6):819-22. PubMed ID: 22739688 [TBL] [Abstract][Full Text] [Related]
32. The malaria vaccine--status quo 2013. Heppner DG Travel Med Infect Dis; 2013; 11(1):2-7. PubMed ID: 23454205 [TBL] [Abstract][Full Text] [Related]
33. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Nardin EH; Nussenzweig RS Annu Rev Immunol; 1993; 11():687-727. PubMed ID: 8476576 [TBL] [Abstract][Full Text] [Related]
34. Advances and challenges in malaria vaccine development. Wang R; Smith JD; Kappe SH Expert Rev Mol Med; 2009 Dec; 11():e39. PubMed ID: 20003658 [TBL] [Abstract][Full Text] [Related]